-
psnet.ahrq.gov/web-mm/deadly-duo
April 28, 2021 - increased awareness of the contribution of pharmacokinetic drug interactions to the toxicity profile of antidepressant … drugs. … Use of antidepressants by general practitioners and psychiatrists in Australia. … CDC: Antidepressants most prescribed drugs in U.S. CNNhealth.com. July 9, 2007. … Antidepressant drugs and the emergence of suicidal tendencies. Drug Saf. 1993;8:186-212.
-
www.ahrq.gov/news/meps-antidepressant-prescription-purchases.html
June 01, 2021 - Prescription antidepressants and antipsychotics are two types of drug therapies sometimes prescribed … As more people use prescription antidepressants and antipsychotics for treatment, it is important for … to 3.5 million, respectively), whereas for men this increase was statistically significant only for antidepressants
-
meps.ahrq.gov/data_files/publications/st163/draft/stat163.shtml
February 01, 2007 - and approximately doubled for anxiolytics, sedatives, and hypnotics (from $0.9 to $2.1 billion) and antidepressants … ), as they did for two subclasses within that class (CNS stimulants, from 11.8 to 19.7 million, and antidepressants … The subclasses include antipsychotics; central nervous system (CNS) stimulants; antidepressants; and … Therapeutic subclass of antidepressants
From 1997 to 2004, total expenditures on antidepressants more … The total number of purchases of antidepressants rose from 88.3 million purchases to 161.2 million purchases
-
meps.ahrq.gov/data_files/publications/st163/stat163.shtml
February 01, 2007 - and approximately doubled for anxiolytics, sedatives, and hypnotics (from $0.9 to $2.1 billion) and antidepressants … ), as they did for two subclasses within that class (CNS stimulants, from 11.8 to 19.7 million, and antidepressants … The subclasses include antipsychotics; central nervous system (CNS) stimulants; antidepressants; and … Therapeutic subclass of antidepressants
From 1997 to 2004, total expenditures on antidepressants more … The total number of purchases of antidepressants rose from 88.3 million purchases to 161.2 million purchases
-
meps.ahrq.gov/data_files/publications/st163/sb163.xml
February 01, 2007 - and approximately doubled for anxiolytics, sedatives, and hypnotics (from $0.9 to $2.1 billion) and antidepressants … The subclasses include antipsychotics; central nervous system (CNS) stimulants; antidepressants; and …
Therapeutic subclass of antidepressants
From 1997 to 2004, total expenditures on … antidepressants more than doubled, rising from $5.1 billion to $12.1 billion (figure 1). … The total number of purchases of antidepressants rose from 88.3 million purchases to 161.2 million purchases
-
srdr.ahrq.gov/projects/592/studies/81918
January 01, 2010 - Reset
Cancel
Study Preview
Study Title and Description
Antidepressants … (Including NSAIDs, acetaminophen, opioids, muscle relaxants, antiseizure medications, antidepressants … Comments ( 0 ) |
Post/View
Title Data
Title
Antidepressants
-
www.ahrq.gov/news/meps-average-expenditures.html
November 01, 2021 - Noninstitutionalized Population
MEPS Statistical Brief #538
Prescription antidepressants … Panel Survey-Household Component (MEPS-HC), presents a comparison of expenditures for prescription antidepressants
-
www.ahrq.gov/news/newsroom/case-studies/coe0902.html
October 01, 2014 - Familiar, a multi-office health clinic in south Texas, uses AHRQ's Effective Health Care guides on antidepressants … The clinic uses "Choosing Antidepressants for Adults for its clinicians and "Antidepressant Medicines … That and the clinician's guide, 'Choosing Antidepressants for Adults,' have helped us keep all our team … The clinician's guide plus AHRQ's 'Comparative Effectiveness of Second-Generation Antidepressants in
-
effectivehealthcare.ahrq.gov/products/depression-pregnancy-postpartum/research
July 08, 2014 - Results
We included 15 observational studies that provided direct evidence on benefits and harms of antidepressants … compared antidepressant treatment with no treatment, and studies of postpartum women also compared antidepressants … This evidence was insufficient to draw conclusions on the comparative benefits or harms of antidepressants … Direct evidence on the risk of major malformations and neonatal development with exposure to antidepressants … for mixed or unreported reasons compared with pregnant women not taking antidepressants whose depression
-
effectivehealthcare.ahrq.gov/products/childhood-depression/protocol
August 24, 2018 - Agents, Second-Generation"[MeSH] OR "Serotonin Uptake Inhibitors"[MeSH] OR "Antidepressive Agents"[MeSH … Agents, Second-Generation/adverse effects"[Mesh] OR "Antidepressive Agents, Second-Generation/poisoning … Agents, Second-Generation"] or [mh "Serotonin Uptake Inhibitors"] or [mh "Antidepressive Agents"] or … Agents, Second-Generation"/AE] or [mh "Antidepressive Agents, Second-Generation"/PO] or [mh "Antidepressive … Agents, Second-Generation” AND “adverse effects”) OR (MH "Antidepressive Agents, Second-Generation”
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary20/depression-in-adults-screening-2009
December 15, 2009 - Antidepressants for depressed elderly. Cochrane Database Syst Rev 2006:CD003491. … Antidepressants and suicide. BMJ 1995;310: 215-8. … Clinical review: relationship between antidepressant drugs and suicidality in adults. … Do SSRIs or antidepressants in general increase suicidality? … Antidepressants reduce the risk of suicide among elderly depressed patients.
-
meps.ahrq.gov/mepsweb/data_stats/Pub_ProdResults_Details.jsp?pt=Statistical+Brief&opt=2&id=1277
June 11, 2021 - Household Component
Publication date:
June 11, 2021
Description:
Prescription antidepressants … As more people use prescription antidepressants and antipsychotics for treatment, it is important for … Estimates are presented separately for antidepressants and antipsychotics.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cer-215-depression-older-adults-executive-summary.pdf
March 01, 2019 - • Few studies compared other antidepressants
to placebo or to each other, or reported other
outcomes … The objective
of this review is to assess comparative adverse
effects of pharmacologic antidepressants … Adverse events of antidepressants versus placebo or no therapy: summary
statements based on findings … Adverse events of antidepressants versus placebo or no therapy: summary
statements based on findings … Adverse events of antidepressants versus placebo or no therapy: summary
statements based on findings
-
meps.ahrq.gov/data_files/publications/st163/stat163.pdf
February 01, 2007 - The subclasses
include antipsychotics; central nervous system (CNS) stimulants;
antidepressants; and … Therapeutic subclass of antidepressants
From 1997 to 2004, total expenditures on antidepressants more … The
total number of purchases of antidepressants rose from 88.3
cy for Healthcare
earch and Quality … 141.9 to 244.3 mil-
s they did for two sub-
s within that class (CNS
nts, from 11.8 to 19.7
, and antidepressants … and 2004
3.4
7.9
5.4
2.12.2
15.3
21.0
32.6
3.3
24.8
0
10
20
30
40
Psychotherapeutics Antidepressants
-
meps.ahrq.gov/data_files/publications/st538/stat538.pdf
November 01, 2021 - Introduction
Prescription antidepressants are widely prescribed to treat a variety of
mental health … This Statistical Brief presents a comparison of
expenditures for prescription antidepressants in the … in 2013 and 2018—therapeutic class: psychotherapeutic
agents; subclass: antidepressants. … For example, bupropion is included in estimates of
antidepressants despite also being assigned to the … Average total, out-of-pocket, and third-party payer
expense per fill for antidepressants, by gender,
-
meps.ahrq.gov/data_files/publications/st538/stat538.shtml
November 01, 2021 - presents a comparison of expenditures for prescription
antidepressants … The
following was used to define antidepressants in 2013 and … 2018-therapeutic class: psychotherapeutic agents; subclass:
antidepressants. … For
example, bupropion is included in estimates of antidepressants … Average total, out-of-pocket, and third-party payer expense per fill for antidepressants, by health insurance
-
effectivehealthcare.ahrq.gov/products/nonopioid-chronic-pain/research
April 16, 2020 - term, improvement in pain and function was small with specific anticonvulsants, moderate with specific antidepressants … of benefit for memantine in fibromyalgia and for serotonin norepinephrine reuptake inhibitor (SNRI) antidepressants … neuropathic pain, pregabalin/gabapentin for fibromyalgia), serotonin-norepinephrine reuptake inhibitor (SNRI) antidepressants … Dose viii reductions reduced the risk of some adverse events with SNRI antidepressants. … In the short term, small improvements in pain and/or function were seen with SNRI antidepressants for
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0352_09-22-2010.pdf
January 01, 2010 - interested in the comparative maternal and fetal benefits and harms of
treatment of depression with antidepressants … have mild, moderate, or severe depression and are pregnant
Intervention(s): Continuing treatment with antidepressants … Comparator(s): Discontinuing, combining, tapering, or switching classes of treatment
with antidepressants … the comparative harms or benefits for both fetus/infant and the mother of
continuing treatment with antidepressants
-
srdrplus.ahrq.gov/published_projects?page=41
June 27, 2021 - Last updated on June 27, 2021 Objectives: Comparison of the benefits and harms of second-generation antidepressants … Last updated on June 27, 2021 Objectives: Comparison of the benefits and harms of second-generation antidepressants … Last updated on June 27, 2021 Objectives: Comparison of the benefits and harms of second-generation antidepressants
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/depression-childhood-protocol.pdf
August 06, 2018 - Agents, Second-Generation"[MeSH] OR "Serotonin
Uptake Inhibitors"[MeSH] OR "Antidepressive Agents"[ … Agents, Second-Generation/adverse effects"[Mesh]
OR "Antidepressive Agents, Second-Generation/poisoning … Agents, Second-Generation"] or [mh "Serotonin Uptake
Inhibitors"] or [mh "Antidepressive Agents"] or … Agents, Second-Generation"/AE] or [mh "Antidepressive
Agents, Second-Generation"/PO] or [mh "Antidepressive … Agents, Second-Generation” AND
“adverse effects”) OR (MH "Antidepressive Agents,
Second-Generation